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Paraneoplastic Scleroderma: Are There Any Clues?
Dear Editor, 
Scleroderma associated with neoplasia is rare, 
with only a small number of cases reported. We de-
scribe 4 patients with paraneoplastic scleroderma 
who were treated at the I. Department of Dermato-
venereology, St. Anna Hospital, during the period be-
tween 2004 and 2014. The patients were diagnosed 
with cholangiogenic carcinoma, endometrial carci-
noma, prostatic adenocarcinoma, and adenoma of 
the suprarenal gland.
In the case of concurrent scleroderma and tumor, 
four situations may occur: they can develop indepen-
dently of each other; scleroderma may be induced by 
the tumor; the tumor can develop in the scleroderma; 
or the tumor can be induced by immunosuppressive 
therapy.
Sclerotization of the skin was described in asso-
ciation with lung cancer, carcinoid, plasma cell dys-
crasia, cancer of the ovary, cervix, breast, esophagus, 
stomach, nasopharynx, melanoma, and sarcoma 
(1,2,5,7,10).
Symptoms may be induced by substances se-
creted by the tumor (hormones, cytokines, etc.) (9). 
Tumorous cells further induce cytotoxic and autoan-
tibody response.
Scleroderma is characterized by immunological 
dysregulation, vasculopathy, and hyperproduction of 
the extracellular matrix by activated fibroblasts. En-
dothelial, inflammatory, and mesenchymal cells pro-
duce cytokines, chemokines, and growth factors e.g. 
Interleukin-1 (IL1), Interleukin-6 (IL6), tumor necrosis 
factor alpha (TNF α), collagen alpha 1, connective 
tissue growth factor (CTGF) (3), and basic fibroblast 
growth factor (bFGF). This factor is also produced by 
lung cancer cells (4).
The clinical picture of scleroderma and para-
neoplastic scleroderma is similar. Diffuse thicken-
ing of the skin and/or sclerodermatous plaques can 
be seen. The histological picture is consistent with 
scleroderma.
Capillaroscopy changes, antinuclear antibodies 
(ANA), sclerodactyly, and Raynaud phenomenon sug-
gest the diagnosis of systemic scleroderma (SS) (4).  
Our patients did not fulfill enough of the criteria 
for SS. Both diffuse and localized scleroderma was 
seen in 3 patients and generalized localized sclero-
derma in one case. All patients had a histological pic-
ture consistent with scleroderma, negative ANA and 
ENA antibodies (Table 1, Figure 1).
A 66-year-old woman presented with a 10 months 
history of sclerodermatous plaques on her neck, 
trunk, and upper and lower extremities. The skin 
on her breasts and cheeks was diffusely indurated. 
Examination showed thrombocytopenia, elevated 
transaminases, Cancer antigen 19-9 (Ca 19-9), thyroid 
stimulating hormone (TSH), and anti-thyroid per-
oxidase antibodies, dysmotility of the lower part of 
esophagus, hepatosplenomegaly, cholecystolithiasis, 
Figure 1.  a) diffuse induration on the forearms; b) diffuse 
induration and scleroderma patches on the legs; c) sclero-
derma patch in the lumbar area, d) diffuse induration on 
the thighs.  
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Patient No Age at 
diagnosis of 
neoplasia 







1 66 years F 10 months Cheeks, neck, breasts, 
abdomen, back, 
upper extremities, 




























70,5 years 12 months
and benign polyps of colon. She was given predni-
sone 40 mg/day but did not return for follow up. Af-
ter 6 months she was diagnosed with cholangiogenic 
carcinoma with metastatic disease and died shortly 
afterwards.
A 74-year-old woman had localized scleroderma 
on the trunk for three years. She was treated with pro-
caine penicillin for positive borrelia Immunoglobulin 
M (IgM) antibodies. Her condition worsened sudden-
ly with confluent scleroderma plaques on her trunk, 
extremities, and genital region, and vasoneurosis on 
her lower extremities; she was started on prednisone 
35 mg/day. Examination revealed endometrial can-
cer. The patient underwent a hysterectomy, adnexec-
tomy, and radiotherapy with curative effect. Sclero-
derma patches softened with residual hyperpigmen-
tation, and prednisone was stopped two years later.
A 80-year-old man had a month-long history of 
diffuse thickening and toughening of the skin on the 
forearms and lower legs and scleroderma patches on 
the thighs and shins. Examination revealed prostate 
adenocarcinoma, and therapy with antiandrogen bi-
calutamide and prednisone 15 mg/day was started. 
Two years after the diagnosis he continues with bi-
calutamide treatment, prednisone 5 mg q.a.d. and 
has residual toughening of the skin on his lower legs.
A 62-year-old woman with seronegative rheuma-
toid arthritis presented with diffusely tough skin on 
her extremities and trunk, present for 2 months. Ex-
amination revealed cervicitis with a benign endomet-
ric polyp, cholecystolithiasis, borderline pulmonary 
hypertension, and a hormonally inactive suprarenal 
adenoma. She was given prednisone 40 mg/day and 
penicillamine with effect. In the 3rd year of therapy 
she has residual induration of her lower legs and a 
scleroderma plaque in the lumbar region. She is mon-
itored for her suprarenal adenoma.
Two patients had scleroderma at the same time 
as a malignant tumor; in one patient the localized 
scleroderma worsened rapidly at the time of the 
tumor diagnosis, and in one patient a clinically si-
lent adenoma was found. Adrenal tissue can secrete 
molecules such as serotonine or bFGF involved in fi-
broplasia (3,6). One patient died of a metastatic dis-
ease, two patients after the successful treatment of 
the tumor, and the patient with suprarenal adenoma 
experienced softening of the skin and regression of 
scleroderma. 
Although paraneoplastic scleroderma is often 
classified as a pseudoscleroderma, we regard neopla-
sia as a distinct triggering impulse for scleroderma. 
Recently, an association between RNA polymerase I/
III antibodies in systemic scleroderma and cancer was 
suggested (8). Such studies may confirm the true link 
between scleroderma and malignancy. These patients 
are characterized by older age, sudden onset, diffuse 
thickening of the skin, and/or generalized morphea 
with a concurrent neoplastic process. In the case of a 
successful tumor treatment, skin changes regress. 
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